TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT03223701

Efficacy of Using Solum IV and BMC With GFC in TLIF

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“Study was never initiated due to contracting issues”

The sponsor’s own words in the registry.

Life of this trial

201720182019Registered2017-07-18Planned start2017-09-30 (planned)Withdrawn (as of)2018-04-18

Vital statistics

Status
Withdrawn
Phase
Phase 4
Sponsor
Seton Healthcare Family
Sponsor type
University, hospital or other
Conditions
Degenerative Disc Disease; Isthmic-lytic Spondylolisthesis; Degenerative Spondylolisthesis; Spinal Stenosis
Interventions
Solum IV, Bone Marrow Concentrate with general fluid concentrate (GFC) in Transforaminal Lumbar Interbody Fusion
Participants
0
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.